These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 928292)

  • 1. [Intravenous isoniazid-sodium glucuronate therapy of tuberculosis (author's transl)].
    Jungbluth H
    Prax Klin Pneumol; 1977 Nov; 31(11):933-5. PubMed ID: 928292
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rapid intravenous administration of isoniazid in treating newly detected destructive pulmonary tuberculosis].
    Shchutskaia EI; Khlebnikova LA; Derbikova TI; Ivanova GT
    Probl Tuberk; 1980 Feb; (2):41-4. PubMed ID: 7375460
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic consequences of measure of inactivation index of isoniazid during antituberculous therapy (author's transl)].
    Houin G; Tillement JP
    Therapie; 1980; 35(5):597-605. PubMed ID: 7209857
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isoniazid therapy with one daily dose (author's transl)].
    Weuta H; Wiechert E
    Prax Pneumol; 1973 Sep; 27(9):518-28. PubMed ID: 4770491
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment efficacy in destructive forms of pulmonary tuberculosis in relation to the methods of administering rifadin and isoniazid].
    Shevchenko RN; German AK; Akhtyrskiĭ AI; Smirnova VV
    Vrach Delo; 1989 Jun; (6):76-8. PubMed ID: 2781771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral ethambutol treatment v. parenteral infusion therapy (author's transl)].
    Reusch G
    Prax Klin Pneumol; 1978 Dec; 32(12):791-801. PubMed ID: 724643
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of patients with destructive pulmonary tuberculosis using intramuscular isoniazid administration].
    Panasiuk AV; Il'nitskiĭ IG; Kunichkina SA; Azarenko II; Lola AT
    Vrach Delo; 1988 Aug; (8):69-71. PubMed ID: 3206888
    [No Abstract]   [Full Text] [Related]  

  • 9. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
    Kameda K; Kino C
    Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
    Zhang LX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of isoniazid in patients with pulmonary tuberculosis].
    Protsiuk RG; Petrenko VI
    Sov Med; 1985; (3):94-8. PubMed ID: 4023845
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in treatment of pulmonary tuberculosis: in terms of bacteriologic relapse (author's transl)].
    Mochizuki K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Sep; 18(9):597-604. PubMed ID: 7289249
    [No Abstract]   [Full Text] [Related]  

  • 13. [Concentration of tuberculostatic drugs introduced by different methods, in the blood of patients].
    Ezerskii VF; Ezerskaia EN
    Probl Tuberk; 1973; 51(1):39-42. PubMed ID: 4742680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum levels of isoniazid in patients with tuberculosis (author's transl)].
    Meier N; Pierart O; Kuhn S; Zabala M; Woywood E; Abarca L; Cortés S
    Rev Med Chil; 1977 Jun; 105(6):390-2. PubMed ID: 897430
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intrabronchial infusion of drugs in pulmonary tuberculosis].
    Ogii NV
    Vrach Delo; 1976 Sep; (9):11-4. PubMed ID: 982958
    [No Abstract]   [Full Text] [Related]  

  • 16. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
    Karkishchenko NN; Khoron'ko VV; Vorob'ev VS; Anisimova NB; Chubarian VT
    Probl Tuberk; 1987; (9):31-4. PubMed ID: 3422964
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immediate results of intravenous chemotherapy of pulmonary tuberculosis in children and adolescents].
    Khruleva TS; Dimakova RN; Paporish SD
    Probl Tuberk; 1971; 49(4):20-4. PubMed ID: 5316446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.